Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Virological characteristics of the SARS-CoV-2 Omicron BA.2.75 variant
Akatsuki Saito, Tomokazu Tamura, Jiří Zahradník, et al.
Cell Host & Microbe (2022) Vol. 30, Iss. 11, pp. 1540-1555.e15
Open Access | Times Cited: 152

Showing 1-25 of 152 citing articles:

The evolution of SARS-CoV-2
Peter V. Markov, Mahan Ghafari, Martin Beer, et al.
Nature Reviews Microbiology (2023) Vol. 21, Iss. 6, pp. 361-379
Open Access | Times Cited: 768
Imprinted SARS-CoV-2 humoral immunity induces convergent Omicron RBD evolution
Yunlong Cao, Fanchong Jian, Jing Wang, et al.
Nature (2022)
Open Access | Times Cited: 565
Virological characteristics of the SARS-CoV-2 XBB variant derived from recombination of two Omicron subvariants
Tomokazu Tamura, Jumpei Ito, Keiya Uriu, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 262
Enhanced neutralization resistance of SARS-CoV-2 Omicron subvariants BQ.1, BQ.1.1, BA.4.6, BF.7, and BA.2.75.2
Panke Qu, John P. Evans, Julia N. Faraone, et al.
Cell Host & Microbe (2022) Vol. 31, Iss. 1, pp. 9-17.e3
Open Access | Times Cited: 242
Resistance of Omicron subvariants BA.2.75.2, BA.4.6, and BQ.1.1 to neutralizing antibodies
Delphine Planas, Timothée Bruel, Isabelle Staropoli, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 169
Enhanced transmissibility, infectivity, and immune resistance of the SARS-CoV-2 omicron XBB.1.5 variant
Keiya Uriu, Jumpei Ito, Jiří Zahradník, et al.
The Lancet Infectious Diseases (2023) Vol. 23, Iss. 3, pp. 280-281
Open Access | Times Cited: 125
Convergent evolution of SARS-CoV-2 Omicron subvariants leading to the emergence of BQ.1.1 variant
Jumpei Ito, Rigel Suzuki, Keiya Uriu, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 121
The rapid rise of SARS‐CoV‐2 Omicron subvariants with immune evasion properties: XBB.1.5 and BQ.1.1 subvariants
Danyi Ao, Xuemei He, Weiqi Hong, et al.
MedComm (2023) Vol. 4, Iss. 2
Open Access | Times Cited: 109
Rational identification of potent and broad sarbecovirus-neutralizing antibody cocktails from SARS convalescents
Yunlong Cao, Fanchong Jian, Zhiying Zhang, et al.
Cell Reports (2022) Vol. 41, Iss. 12, pp. 111845-111845
Open Access | Times Cited: 101
Distinct Neutralizing Antibody Escape of SARS-CoV-2 Omicron Subvariants BQ.1, BQ.1.1, BA.4.6, BF.7 and BA.2.75.2
Panke Qu, John P. Evans, Julia N. Faraone, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 80
Virological characteristics of the SARS-CoV-2 BA.2.86 variant
Tomokazu Tamura, Keita Mizuma, Hesham Nasser, et al.
Cell Host & Microbe (2024) Vol. 32, Iss. 2, pp. 170-180.e12
Open Access | Times Cited: 63
Virological characteristics of the SARS-CoV-2 Omicron XBB.1.5 variant
Tomokazu Tamura, Takashi Irie, Sayaka Deguchi, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 49
Evolution of enhanced innate immune suppression by SARS-CoV-2 Omicron subvariants
Ann‐Kathrin Reuschl, Lucy Thorne, Matthew Whelan, et al.
Nature Microbiology (2024) Vol. 9, Iss. 2, pp. 451-463
Open Access | Times Cited: 45
Evolution of the SARS-CoV-2 Omicron Variants: Genetic Impact on Viral Fitness
Wenhao Liu, Zehong Huang, Jin Xiao, et al.
Viruses (2024) Vol. 16, Iss. 2, pp. 184-184
Open Access | Times Cited: 24
Identification of a highly conserved neutralizing epitope within the RBD region of diverse SARS-CoV-2 variants
Yanqun Wang, An Yan, Deyong Song, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 18
Phenotypic evolution of SARS-CoV-2 spike during the COVID-19 pandemic
Wilhelm Furnon, Vanessa M. Cowton, Giuditta De Lorenzo, et al.
Nature Microbiology (2025)
Open Access | Times Cited: 2
The Omicron variant of concern: Diversification and convergent evolution in spike protein, and escape from anti-Spike monoclonal antibodies
Daniele Focosi, Scott A. McConnell, Arturo Casadevall
Drug Resistance Updates (2022) Vol. 65, pp. 100882-100882
Open Access | Times Cited: 41
The viral fitness and intrinsic pathogenicity of dominant SARS-CoV-2 Omicron sublineages BA.1, BA.2, and BA.5
Huiping Shuai, Jasper Fuk‐Woo Chan, Bingjie Hu, et al.
EBioMedicine (2023) Vol. 95, pp. 104753-104753
Open Access | Times Cited: 38
Nirmatrelvir and COVID-19: development, pharmacokinetics, clinical efficacy, resistance, relapse, and pharmacoeconomics
Daniele Focosi, Scott A. McConnell, Shmuel Shoham, et al.
International Journal of Antimicrobial Agents (2023) Vol. 61, Iss. 2, pp. 106708-106708
Open Access | Times Cited: 31
Markov State Models and Perturbation-Based Approaches Reveal Distinct Dynamic Signatures and Hidden Allosteric Pockets in the Emerging SARS-Cov-2 Spike Omicron Variant Complexes with the Host Receptor: The Interplay of Dynamics and Convergent Evolution Modulates Allostery and Functional Mechanisms
Sian Xiao, Mohammed Alshahrani, Grace Gupta, et al.
Journal of Chemical Information and Modeling (2023) Vol. 63, Iss. 16, pp. 5272-5296
Open Access | Times Cited: 31
Omicron subvariant BA.5 efficiently infects lung cells
Markus Hoffmann, Lok-Yin Roy Wong, Prerna Arora, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 30
Resistance to nirmatrelvir due to mutations in the Mpro in the subvariants of SARS-CoV-2 Omicron: Another concern?
Srijan Chatterjee, Manojit Bhattacharya, Kuldeep Dhama, et al.
Molecular Therapy — Nucleic Acids (2023) Vol. 32, pp. 263-266
Open Access | Times Cited: 27
Virological characteristics of the SARS-CoV-2 BA.2.86 variant
Tomokazu Tamura, Keita Mizuma, Hesham Nasser, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 27
Antigenic evolution of SARS coronavirus 2
Anna Z. Mykytyn, Ron A. M. Fouchier, Bart L. Haagmans
Current Opinion in Virology (2023) Vol. 62, pp. 101349-101349
Open Access | Times Cited: 26
SARS-CoV-2 Omicron subvariants exhibit distinct fusogenicity, but similar sensitivity, to pan-CoV fusion inhibitors
Shuai Xia, Lijue Wang, Fanke Jiao, et al.
Emerging Microbes & Infections (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 25
Page 1 - Next Page

Scroll to top